Amazon intros low upfront telehealth pricing for some conditionsPrime members can treat some health, beauty and lifestyle conditions for as little as $10 per month. Walgreens, Dion’s Dream Chicago host Dream Vault Smart Locker in Gage Park storeThe Dream Vault will provide free produce to more than 175 local households per week. The 10 top states where people live the longest Massachusetts ranks first on the list of top U.S. states where people live the longest. Watch DSN: Healthcare collaboration boosts outcomes for GLP-1 patients Amanda Jochum, a registered dietitian with Hy-Vee, discusses GLP-1 medication side effects, patient support strategies and beneficial product recommendations. Camber releases generic Xeloda Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers. Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza Liraglutide, used to treat Type 2 diabetes, belongs to the first generation of GLP-1 agonists. FDA gives Lupin tentative nod for generic Isentress Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus infection. Alembic obtains FDA nod for generic Cardizem Generic Cardizem is indicated for the treatment of hypertension and the management of chronic stable angina and angina due to coronary artery spasm. Bora Pharmaceuticals acquires Pyros Pharmaceuticals Pyros is a specialty pharmaceutical company developing treatments for rare diseases. Who's using GLP-1s? Obesity patients earning over $250,000 annually are 72% more likely to take a GLP-1 than those earning $50,000 or less, per a new study. First Previous 5 6 7 8 9 Next Last
